跳至主要内容
临床试验/NCT00659919
NCT00659919已完成4 期

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

BeerYaakov Mental Health Center1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2000年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
13
试验地点
1
主要终点
Barnes Akathisia rating scale, Positive and Negative syndrome scale, Hamilton Depression Rating Scale, Hamilton Anxiety Scale, Clinical Global Impression, Scale for the Assessment of Negative Symptoms

研究概览

简要总结

Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with akathisia according to DSM-IV criteria at least mild akathisia.

排除标准

  • Change of pharmacologic regimen 7 days prior to study entry
  • Significant systemic disease
  • The presence of chronic akathisia
  • Patients unable to cooperate

研究组 & 干预措施

Placebo

Placebo Comparator

The patients in this arm received placebo

干预措施: Placebo (Drug)

Trazodone

Active Comparator

The patients on this arm received Trazodone for 3 consecutive days

干预措施: Trazodone (Drug)

结局指标

主要结局

Barnes Akathisia rating scale, Positive and Negative syndrome scale, Hamilton Depression Rating Scale, Hamilton Anxiety Scale, Clinical Global Impression, Scale for the Assessment of Negative Symptoms

次要结局

未报告次要终点

研究者

发起方
BeerYaakov Mental Health Center
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验

Treatment of Neuroleptic Induced Acute Akathisia... | 临床试验